DM
Deerfield Management’s Xeris Biopharma Holdings XERS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $105K | Buy |
+22,574
| New | +$105K | ﹤0.01% | 114 |
|
2024
Q2 | – | Sell |
-73,570
| Closed | -$163K | – | 578 |
|
2024
Q1 | $163K | Buy |
+73,570
| New | +$163K | ﹤0.01% | 345 |
|
2021
Q3 | – | Sell |
-6,553,398
| Closed | -$26.7M | – | 153 |
|
2021
Q2 | $26.7M | Hold |
6,553,398
| – | – | 0.47% | 70 |
|
2021
Q1 | $29.6M | Buy |
+6,553,398
| New | +$29.6M | 0.62% | 54 |
|
2020
Q3 | – | Sell |
-3,178,551
| Closed | -$8.46M | – | 115 |
|
2020
Q2 | $8.46M | Sell |
3,178,551
-254,740
| -7% | -$678K | 0.25% | 79 |
|
2020
Q1 | $6.7M | Buy |
3,433,291
+850,000
| +33% | +$1.66M | 0.21% | 79 |
|
2019
Q4 | $18.2M | Buy |
2,583,291
+274,625
| +12% | +$1.94M | 0.58% | 54 |
|
2019
Q3 | $22.7M | Sell |
2,308,666
-71,235
| -3% | -$700K | 0.93% | 37 |
|
2019
Q2 | $27.2M | Buy |
2,379,901
+24,765
| +1% | +$283K | 0.98% | 34 |
|
2019
Q1 | $23.6M | Sell |
2,355,136
-143,530
| -6% | -$1.44M | 0.91% | 38 |
|
2018
Q4 | $42.5M | Hold |
2,498,666
| – | – | 1.7% | 18 |
|
2018
Q3 | $43.9M | Hold |
2,498,666
| – | – | 1.57% | 23 |
|
2018
Q2 | $47.4M | Buy |
+2,498,666
| New | +$47.4M | 1.67% | 14 |
|